Day: March 5, 2026

OLAPLEX Reports Fourth Quarter and Fiscal Year 2025 Results

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

NEW YORK, NY, March 05, 2026 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: “We ended 2025 on a high note with fourth quarter sales growth of 4.3%. In 2025, we delivered on our Bonds & Beyond transformation priorities, driving renewed brand momentum and building a consistent innovation pipeline while strengthening execution and sharpening strategic focus. As we enter 2026, we do so with a clear path forward and a more balanced, sustainable approach to investment and growth.” For the fourth quarter of 2025 compared to the fourth quarter of 2024:Net sales increased 4.3% to $105.1 million;By...

Brilliant Earth Reports Record Quarterly Net Sales

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

Delivered 4% Y/Y Net Sales Growth Drove 34% Y/Y Bookings Growth in Fine JewelryProvides Q1 and Full Year Guidance 2026 SAN FRANCISCO, March 05, 2026 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three and twelve months ended December 31, 2025. Fourth Quarter and Fiscal Year 2025 Highlights (quarterly and annual periods ended December 31, 2025):Delivered Net Sales of $124.4 million and $437.5 million in the fourth quarter and fiscal year, respectively.Largest quarter ever of Net Sales Total orders grew year-over-year 7% in Q4 and 13% in 2025 Repeat orders grew year-over-year 15% in Q4 and 13% in 2025 Average Selling Price (ASP) grew year-over-year across the assortment...

Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

– KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, supporting ongoing development plans targeting up to 50% of AML patients – – Orange Book listing of patents extending up to 2044 reinforces long-term value for KOMZIFTI – – FIT-001 Phase 1b dose expansion initiated for darlifarnib and cabozantinib combination in advanced renal cell carcinoma – – Multiple 2026 clinical data milestones expected across AML and solid tumor programs – – Strong capital position of $667.2 million in cash, cash equivalents and short-term investments, together with $180 million in anticipated collaboration payments, expected to support advancement of ziftomenib AML program to first topline Phase 3 results in...

HUTCHMED Reports 2025 Full Year Results and Business Updates

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

— Geographic expansion driving ex-China sales growth; indication expansions driving China sales growth — — $457 million net income, driven by profitable core operations and non-core disposal — — Rapidly progressing groundbreaking ATTC technology, a source of novel drug candidates with broad therapeutic potential — — Pursuing potential opportunities for partnering ATTC candidates with multinational pharmaceutical companies — HONG KONG and SHANGHAI and FLORHAM PARK, N.J. , March 05, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) (Nasdaq/AIM:HCM; HKEX:13) today reports its financial results for the year ended December 31, 2025 and provides updates on key clinical and commercial developments. HUTCHMED to host results webcasts at 8:00 a.m. EST / 1:00 p.m. GMT / 9:00 p.m. HKT in English on Thursday,...

Municipality Finance Group’s Annual Report for 2025 published

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

Municipality Finance PlcStock exchange release5 March 2026 at 1:00 pm (EET) Municipality Finance Group’s Annual Report for 2025 published Municipality Finance Group’s Annual Report and Corporate Governance Statement for the year 2025 have been published in English and Finnish. MuniFin Group’s Annual Report fulfils the reporting requirements of European Single Electronic Format (ESEF). In accordance with these requirements, Report of the Board of Directors and the Consolidated Financial Statements are published not only in the Annual Report file but additionally in a separate zip file in which Report of the Board and the Financial Statements are marked up with XBRL tags. These ESEF Financial Statements have been subject to an independent auditor’s assurance. MuniFin Group has also published Pillar 3 Disclosure document in accordance with...

Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 – Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter of 2026 –AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided recent business highlights. “SL-325 is now the first DR3 blocking antibody to generate human clinical data, and we are very pleased with the progress we have made in our...

AH Realty Trust, Previously Armada Hoffler, Announces Quarterly Dividend

Written by Customer Service on March 5, 2026. Posted in Dividend Reports And Estimates.

VIRGINIA BEACH, Va., March 05, 2026 (GLOBE NEWSWIRE) — AH Realty Trust (NYSE: AHRT), previously Armada Hoffler, announced that its Board of Directors declared the company’s regular quarterly cash dividend of $0.14 per common share. The first quarter dividend will be paid in cash on April 2, 2026, to stockholders of record on March 26, 2026. The Board of Directors also declared a cash dividend of $0.421875 per share on its 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock payable on April 15, 2026, to stockholders of record on April 1, 2026. About AH Realty Trust AH Realty Trust (NYSE: AHRT), formerly known as Armada Hoffler, is a real estate investment trust (“REIT”) with over four decades of experience. The company owns and operates high-quality retail and office assets located primarily in the Mid-Atlantic and Southeastern...

Duluth Holdings Inc. to Report Fourth Quarter 2025 Financial Results on March 19, 2026

Written by Customer Service on March 5, 2026. Posted in Public Companies.

MOUNT HOREB, Wis., March 05, 2026 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear, and accessories, today announced that it will report fourth quarter 2025 financial results before market on Thursday, March 19, 2026. A conference call and audio webcast with analysts and investors will be held on Thursday, March 19, 2026, at 9:30 am Eastern Time to discuss the results and answer questions. Live conference call: 1-844-875-6915 (domestic) or 1-412-317-6711 (international)Conference call replay available through March 26, 2026: 1-855-669-9658 (domestic) or 1-412-317-0088 (international)Replay access code: 2766842 Live and archived webcast: ir.duluthtrading.com To expedite entry into the call and avoid waiting for...

BIO-key Surpasses $2M of Military/Defense Sales over Last 12 months with Follow-on Order From Foreign Defense Ministry; Geopolitical Tensions Raise Stakes for Securing Intelligence Against Cyber Threats

Written by Customer Service on March 5, 2026. Posted in Public Companies.

HOLMDEL, N.J., March 05, 2026 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), a provider of biometric-centric Identity and Access Management (IAM) solutions, today announced that the cyber-defense unit of a foreign defense ministry placed a $280,000 in new order to expand its deployment of BIO-key’s biometric user authentication to additional personnel. The order brings total business booked from this customer in the past 12 months to $1.14M with additional orders expected. Across the broader military and defense sector BIO-key has secured over $2M in total orders over the last 12 months, representing a substantial increase over the year-ago period. Rising geopolitical tensions, particularly in the Middle East, have increased demand for hardened authentication across foreign defense and intelligence agencies. BIO-key’s...

Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Written by Customer Service on March 5, 2026. Posted in Earnings Releases And Operating Results.

SHANGHAI, March 05, 2026 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights:Average daily active users (DAUs) were 113.0 million, an increase of 10% year over year. Average daily time spent per active user were 107 minutes, an increase of 8% year over year. Total net revenues were RMB8.32 billion (US$1,189.9 million), an increase of 8% year over year. Advertising revenues, a key driver of total net revenues, were RMB3.04 billion (US$435.0 million), an increase of 27% year over year. Gross profit was RMB3.08 billion (US$440.6 million), an increase of 11% year over year....

Day: March 5, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals